D-4F and L-5F improves blood glucose. by Kristine C. McGrath (8269155)

Combination treatment with LY294002 and tamoxifen remarkably decreased AKT and GSK-3β phosphorylation in C6 glioma cells. by Cuixian Li (341124)

E2-induced PKCδ activation is responsible for the ASL height decrease in CuFi-1 cells. by Vinciane Saint-Criq (479729)

dsRNA-induced decrease in Mcl-1 protein expression depends on eIF2α phosphorylation by PKR. by Maikel L. Colli (179059)

Expression of MHC II decreased in old Gas7-deficient soleus while MHC I expression increased. by Bo-Tsang Huang (162584)

NR2F2 binds the variant rs3743462-C oligonucleotide with higher affinity than the rs3743462-T oligonucleotide and the C-allele is associated with a strong decrease of <i>NR2F2</i> gene expression relative to the T-allele. by Marie Boutant (164748)

Average self-reported physical health ratings before or during the COVID-19 pandemic among individuals who engaged during the pandemic in more than 3 (A), 4 (B), or 5 (C) positive... by Elie Mulhem (22537863)

A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

“…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”

Mean decrease in accuracy (MDA) of top 15 urine metabolites. by Liam E. Broughton-Neiswanger (8447220)

“…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…”

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a time-dependent manner. by Lan Zhang (90951)

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a dose-dependent manner. by Lan Zhang (90951)

BECN1 knockdown and BCL-W/BCL2 co-inhibition decreases cell proliferation through increased apoptosis in resistant cells. by Anatasha C. Crawford (255140)

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

mTOR inhibition with rapamycin decreases MEC survival and branching. by Meghan M. Morrison (683792)

RNF5 depletion decreases cellular gene expression and lytic replication through increased EphA3 and EphA4 level in iSLK.219 cells. by Xiaojuan Li (351842)

Inhibition of TRPC3 decreases ATP- and OAG-induced Ca²⁺ transients in striatal astrocytes. by Karin M. Streifel (653838)

“…Prior treatment with Pyr3 for 30 minutes at 37°C decreased the Ca²⁺ response to ATP, whereas only a modest additive effect was observed with Pyr3 in the presence of 10 µM MPP⁺. …”

AT2R blocker reduces T3-induced decreased levels of contractile proteins and attenuates T3-induced NO production. by Maria Alícia Carrillo-Sepúlveda (406779)

“…Data are expressed as mean ± SD (n = 5 per group for A and B; n = 4 per group for C and D; *p<0.05 <i>vs.…”

The decreased inflammation in the liver of the CD45.2⁺ recipient mice that were adoptively transferred with InCsEVs-BMDMs. by Beibei Zhang (509356)

Gal-9 treatment decreases levels of MMP-9, MMP-2 and TIMP-1 but not neutrophil chemoattractants in BALF. by Yuko Horio (4243405)